Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study: Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body Radiotherapy and REsection

NCT02433574 is registered in ClinicalTrials.gov with Juravinski Cancer Center as lead sponsor.

NCT NCT02433574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02433574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study: Locally Invasive NSCLC Treated With NEo-Adjuvant Stereotactic Body Radiotherapy and REsection
Lead sponsor
Juravinski Cancer Center
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2015
Completion date
January 31, 2019
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung cancer